Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | LDHA | P00338 | 4/20 | 0.53 |
| ▸ | LDHB | P07195 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | HTT | P42858 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | NAMPT | P43490 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11669485 | 0.86 | LDHA (0.52) | SMN1; SMN2LDHALDHBALDH1A1TSHR | |
| SCHEMBL5918187 | 0.83 | LDHA (0.60) | SMN1; SMN2LDHALDHBALDH1A1TSHR | |
| SCHEMBL6920434 | 0.83 | MAPT (0.54) | SMN1; SMN2LDHALDHBALDH1A1TSHR | |
| SCHEMBL6563493 | 0.83 | HTT (0.49) | SMN1; SMN2LDHALDHBALDH1A1TSHR | |
| SCHEMBL5604635 | 0.82 | TSHR (0.49) | SMN1; SMN2LDHALDHBALDH1A1TSHR | |
| Bromide SCHEMBL7373319 | 0.81 | RAB9A (0.48) | SMN1; SMN2LDHALDHBALDH1A1TSHR | |
| SCHEMBL4199041 | 0.80 | HTT (0.47) | SMN1; SMN2LDHALDHBALDH1A1TSHR | |
| SCHEMBL7716484 | 0.80 | KMT2A (0.53) | SMN1; SMN2LDHALDHBALDH1A1RAB9A | |
| SCHEMBL28865452 | 0.79 | GAA (0.56) | SMN1; SMN2LDHALDHBALDH1A1TSHR | |
| SCHEMBL15197114 | 0.79 | SMN1; SMN2 (0.58) | SMN1; SMN2LDHALDHBALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101484163-A | 2-Benzoyl-imidazopyridine derivatives, their preparation and their therapeutic use | SANOFI AVENTIS (FR) | 2009-07-15 | — | — | CN | claimed |
| EP-0007678-B1 | OXIME ETHERS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ACF CHEMIEFARMA NV (NL) | 1983-03-30 | — | — | EP | claimed |
| EP-0007678-A1 | Oxime ethers, their preparation and pharmaceutical compositions containing them | ACF CHEMIEFARMA NV (NL) | 1980-02-06 | — | — | EP | claimed |
| WO-2024030651-A1 | GPX4 INHIBITORS AND USE THEREOF | SONATA THERAPEUTICS, INC. (US) | 2024-02-08 | — | — | WO | disclosed |
| US-8981111-B2 | Fungicide hydroximoyl-heterocycles derivatives | BAYER CROPSCIENCE AG (DE) | 2015-03-17 | — | — | US | disclosed |
| US-20110034445-A1 | FUNGICIDE HYDROXIMOYL-HETEROCYCLES DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2011-02-10 | — | — | US | disclosed |
| EP-2271641-A1 | FUNGICIDE HYDROXIMOYL-HETEROCYCLES DERIVATIVES | Bayer CropScience AG (DE) | 2011-01-12 | — | — | EP | disclosed |
| WO-2009130193-A1 | FUNGICIDE HYDROXIMOYL-HETEROCYCLES DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2009-10-29 | — | — | WO | disclosed |
| CN-101484163-A | 2-Benzoyl-imidazopyridine derivatives, their preparation and their therapeutic use | SANOFI AVENTIS (FR) | 2009-07-15 | — | — | CN | disclosed |
| US-20050020660-A1 | Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors | UCB, S.A. (BE) | 2005-01-27 | — | — | US | disclosed |
| EP-0007678-B1 | OXIME ETHERS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ACF CHEMIEFARMA NV (NL) | 1983-03-30 | — | — | EP | disclosed |
| US-4352804-A | ANTIULCER AGENTS, GASTROINTESTINAL DISORDERS | ACF CHEMIEFARMA NV (NL) | 1982-10-05 | — | — | US | disclosed |
| EP-0007678-A1 | Oxime ethers, their preparation and pharmaceutical compositions containing them | ACF CHEMIEFARMA NV (NL) | 1980-02-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110034445-A1 | FUNGICIDE HYDROXIMOYL-HETEROCYCLES DERIVATIVES | HAAO, HPD, CYP51A1 | SMN1; SMN2 4257/4885LDHA 3052/4885LDHB 2691/4885 |
| US-20050020660-A1 | Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors | CHRM2, CHRM3, CHRM1 | SMN1; SMN2 2829/4885LDHA 3098/4885LDHB 2921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.